*ST南糖(000911.SZ)擬公開掛牌轉讓參股公司八鯉建材48.03%股權
格隆匯4月20日丨*ST南糖(000911.SZ)公佈,南寧市八鯉建材有限公司(“八鯉建材”)為公司的參股公司,公司持有其48.03%股份。公司擬在北部灣產權交易所集團股份有限公司(“產權交易所”)公開掛牌轉讓公司所持有的八鯉建材48.03%的股權,掛牌底價為人民幣1765.63萬元。
南寧市八鯉建材有限公司經營範圍:生產銷售普通硅酸鹽水泥、水泥製品及砌塊(涉及許可證憑有效期許可證經營)。(依法須經批准的項目,經有關部門批准後方可開展經營活動)
轉讓公司所持八鯉建材股權有利於進一步優化資產結構,提高資產的運營效率,符合公司發展的需要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.